Vitamin D DeficiencyNCT01105689
Utility of a Urine Screening Tool for Vitamin D Deficiency in Infants and Toddlers
An observational study of Vitamin D Deficiency, run by Nemours Children's Clinic at 1 site in United States.
Trial summary
Background: Vitamin D plays a key role in calcium absorption in the gut and in skeletal development. Vitamin D deficiency is common, affecting an estimated one billion people worldwide, including developed countries. Vitamin D deficiency causes rickets, the most common non-communicable disease of childhood. Read more about this study
- Who is it for?
- Ages 6 months to 3 yearsHealthy volunteers can take part
- Conditions the study is for
- Vitamin D Deficiency
- How many people
- 60 participants
- Where
- 1 siteUnited States
- Study dates
- Mar 2010to Jul 2011
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 6 months to 3 years
- All sexes
- Healthy volunteers accepted
- Child
Study population: Infants and Toddlers from 6 months to 3 years part of a group known to be in at least one high-risk group for vitamin D deficiency: 1. child has been exclusively breast fedfor at least 1 month 2. darkly pigmented children 3. children born at a gestational age of 32 weeks or less 4. recent immigrant from developed country 5. child is underweight (wt/ht < 10%) 6. children with bowed legs or wrist enlargement
Who may be able to join
- In one of the 6 high-risk groups between the age of 6 months and 3 years.
Who cannot join
- known familial rickets (hypophosphatemic or vitamin D resistant)
- known parathyroid hormone problems
- any child on diuretics
- presence of a chronic disease or use of medications known to affect vitamin D metabolism
- renal insufficiency
- known malabsorption
- rickets secondary to other syndromes (e.g. Fanconi syndrome)
Trial locations and contacts
1 site in 1 country.
United States1 site
Nemours Children's Clinic
Jacksonville, Florida, 32207
About this study
Official title: Utility of the Urine Calcium Creatinine Ratio as a Screening Tool for Vitamin D Deficiency in Infants and Toddlers
Background:
Vitamin D plays a key role in calcium absorption in the gut and in skeletal development. Vitamin D deficiency is common, affecting an estimated one billion people worldwide, including developed countries. Vitamin D deficiency causes rickets, the most common non-communicable disease of childhood. Rickets causes poor growth and skeletal deformities and, at its most severe, seizures and death. Recent data suggest that children with rickets have an increased risk for developing diabetes mellitus.
Read more
Screening for vitamin D deficiency is not commonly done. It is generally diagnosed only after symptoms of rickets have developed. Prevention and treatment is simple and inexpensive. Hence, early detection of vitamin D deficiency through screening would be beneficial. Studies are urgently needed to validate such screening tests.
Calcium balance is tightly regulated in the body and calcium loss in the urine (measured by the urine calcium-to-creatinine ratio) is a sensitive indicator of reduced calcium absorption, such as in vitamin D deficiency.
Objective and Hypotheses. The objective of this study is to evaluate the urine calcium-to-creatinine ratio as a noninvasive and inexpensive screening test for vitamin D deficiency. Our hypotheses are 1) that the urine calcium-to-creatinine ratio correlates with blood vitamin D levels in infants and toddlers at risk for vitamin D deficiency and 2) that this test can be used to screen for vitamin D deficiency.
Potential Impact. A validated screening tool would allow for the detection of vitamin D deficiency before the development of rickets, decreasing the morbidity and mortality of this common disease.
Read the detailed description
Background:
Insufficient circulating levels of vitamin D is a common problem in both developed and developing countries; it is estimated that over one billion people have vitamin D deficiency at this time. In children, vitamin D deficiency leads to nutritional rickets, which is considered the most common non-communicable disease of children worldwide. Rickets causes significant short term morbidity and mortality through hypocalcemic tetany and seizures, as well as long term morbidity from growth delay and skeletal deformities. Recent data also suggest that children who have had nutritional rickets are three times more likely to develop type 1 diabetes.
There is wide agreement that screening for vitamin D deficiency would be highly beneficial. However, there is debate on how best to do this. Most screening efforts have included serum levels of 25-hydroxy-vitamin D and parathyroid hormone (PTH). However, these assays are complex and are neither available nor affordable for many of the most vulnerable populations.
Calcium excretion in the kidney is a tightly regulated process involving metabolites of vitamin D and PTH. Renal calcium excretion, in the absence of primary renal or parathyroid gland disease, is a sensitive indicator of total body calcium balance. We have shown that renal calcium excretion correlates with blood levels of 25-hydroxy-vitamin D levels in older children and urine calcium-to-creatinine ratios have been shown to distinguish children with active rickets from healthy controls in one Nigerian study. This biomarker is noninvasive and the assays are straight forward and inexpensive. We believe that the urine calcium-to-creatinine ratio has excellent potential as a screening tool for vitamin D deficiency.
Objective and Hypotheses. The objective of this study is to evaluate the urine calcium-to-creatinine ratio as a biomarker of vitamin D deficiency. Our hypotheses are 1) that urine calcium-to-creatinine ratio correlates with serum 25-hydroxy vitamin D level in infants and toddlers at risk for vitamin D deficiency and 2) that the urine calcium-to-creatinine ratio can be used to screen children for vitamin D deficiency. These hypotheses will be tested through two specific aims. Specific Aim 1 is to determine the correlation between the urine calcium-to-creatinine ratio with 25-hydroxy vitamin D levels and with biomarkers of rickets in infants and toddlers at increased risk for vitamin D deficiency. Specific Aim 2 is to determine the sensitivity, specificity, and positive and negative predictive values of one random urine calcium-to-creatinine ratio in relation to biochemical evidence of vitamin D deficiency.
Design. This will be an observational study of infants and toddlers at increased risk for vitamin D deficiency. We will recruit 150 healthy children, 6 to 36 months of age, with risk factors for vitamin D deficiency (premature birth, breast feeding, dairy product avoidance, etc.). Based on previous studies in the US, we anticipate about 12% of these subjects will have vitamin D deficiency. Subjects will have a physical exam targeted to signs of rickets. Laboratories will include a random urine sample for calcium-to-creatinine ratio and blood for calcium, creatinine, alkaline phosphatase, phosphorus, magnesium, intact PTH, and 25-hydroxy vitamin D. Subjects with biochemical evidence of rickets will have x-rays done of the left wrist and knees that will be scored according to previously published rickets scores.
Potential Impact. Vitamin D deficiency is increasingly recognized as a common source of morbidity in both developed and undeveloped countries. The validation of a noninvasive and inexpensive screening tool for vitamin D deficiency would allow for large scale screening of at risk populations and detect this problem early, preventing the morbidities of rickets.
- Conditions
- Vitamin D Deficiency
- Keywords
- Urine Calcium to Creatinine Ratio, Hypocalciuria, Infants, Toddlers
- Medical subject headings
- Vitamin D Deficiency
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Apr 2010 (estimated)
- Study startMar 2010
- Primary completionJul 2011
- Study completionJul 2011
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (5)Papers the sponsor has linked to this study.
- Other trials for Vitamin D DeficiencyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Enrolment
- 60 participants (actual)
Sponsor and investigators
- Lead sponsor
- Nemours Children's Clinic
- Sponsor type
- University, hospital or other
- Investigators
- Robert Olney, MD, Principal investigator, Nemours Children's ClinicMatthew Benson, MD, Study director, Nemours Children's Clinic
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01105689
- Sponsor's protocol ID
- 09-171
- Status last verified
- Sep 2011
- First submitted
- 15 Apr 2010
- Last updated
- 9 Sep 2011
- Results posted
- No
- Data monitoring committee
- No
Publications
Olney RC, Mazur JM, Pike LM, Froyen MK, Ramirez-Garnica G, Loveless EA, Mandel DM, Hahn GA, Neal KM, Cummings RJ. Healthy children with frequent fractures: how much evaluation is needed? Pediatrics. 2008 May;121(5):890-7. doi: 10.1542/peds.2007-2079.
PubMed 18450891Gordon CM, Feldman HA, Sinclair L, Williams AL, Kleinman PK, Perez-Rossello J, Cox JE. Prevalence of vitamin D deficiency among healthy infants and toddlers. Arch Pediatr Adolesc Med. 2008 Jun;162(6):505-12. doi: 10.1001/archpedi.162.6.505.
PubMed 18524739Thacher TD, Fischer PR, Pettifor JM, Lawson JO, Manaster BJ, Reading JC. Radiographic scoring method for the assessment of the severity of nutritional rickets. J Trop Pediatr. 2000 Jun;46(3):132-9. doi: 10.1093/tropej/46.3.132.
PubMed 10893912Thacher TD, Fischer PR, Pettifor JM, Lawson JO, Isichei CO, Chan GM. Case-control study of factors associated with nutritional rickets in Nigerian children. J Pediatr. 2000 Sep;137(3):367-73. doi: 10.1067/mpd.2000.107527.
PubMed 10969262Thacher TD, Fischer PR, Pettifor JM. The usefulness of clinical features to identify active rickets. Ann Trop Paediatr. 2002 Sep;22(3):229-37. doi: 10.1179/027249302125001525.
PubMed 12369487
Study at a glance
From the registry record, last updated by the sponsor on 9 Sep 2011. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Utility of the Urine Calcium Creatinine Ratio as a Screening Tool for Vitamin D Deficiency in Infants and Toddlers
- ClinicalTrials.gov ID
- NCT01105689
- Acronym / sponsor ID
- 09-171
- Conditions
- Vitamin D Deficiency
- Keywords
- Urine Calcium to Creatinine Ratio, Hypocalciuria, Infants, Toddlers
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 60 participants (actual)
- Lead sponsor
- Nemours Children's ClinicUniversity, hospital or other
- Study start
- Mar 2010
- Primary completion
- Jul 2011 (actual)
- Study completion
- Jul 2011 (actual)
- First posted
- 16 Apr 2010 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Background:
Vitamin D plays a key role in calcium absorption in the gut and in skeletal development. Vitamin D deficiency is common, affecting an estimated one billion people worldwide, including developed countries. Vitamin D deficiency causes rickets, the most common non-communicable disease of childhood. Rickets causes poor growth and skeletal deformities and, at its most severe, seizures and death. Recent data suggest that children with rickets have an increased risk for developing diabetes mellitus.
Screening for vitamin D deficiency is not commonly done. It is generally diagnosed only after symptoms of rickets have developed. Prevention and treatment is simple and inexpensive. Hence, early detection of vitamin D deficiency through screening would be beneficial. Studies are urgently needed to validate such screening tests.
Calcium balance is tightly regulated in the body and calcium loss in the urine (measured by the urine calcium-to-creatinine ratio) is a sensitive indicator of reduced calcium absorption, such as in vitamin D deficiency.
Objective and Hypotheses. The objective of this study is to evaluate the urine calcium-to-creatinine ratio as a noninvasive and inexpensive screening test for vitamin D deficiency. Our hypotheses are 1) that the urine calcium-to-creatinine ratio correlates with blood vitamin D levels in infants and toddlers at risk for vitamin D deficiency and 2) that this test can be used to screen for vitamin D deficiency.
Potential Impact. A validated screening tool would allow for the detection of vitamin D deficiency before the development of rickets, decreasing the morbidity and mortality of this common disease.
Detailed description
Background:
Insufficient circulating levels of vitamin D is a common problem in both developed and developing countries; it is estimated that over one billion people have vitamin D deficiency at this time. In children, vitamin D deficiency leads to nutritional rickets, which is considered the most common non-communicable disease of children worldwide. Rickets causes significant short term morbidity and mortality through hypocalcemic tetany and seizures, as well as long term morbidity from growth delay and skeletal deformities. Recent data also suggest that children who have had nutritional rickets are three times more likely to develop type 1 diabetes.
There is wide agreement that screening for vitamin D deficiency would be highly beneficial. However, there is debate on how best to do this. Most screening efforts have included serum levels of 25-hydroxy-vitamin D and parathyroid hormone (PTH). However, these assays are complex and are neither available nor affordable for many of the most vulnerable populations.
Calcium excretion in the kidney is a tightly regulated process involving metabolites of vitamin D and PTH. Renal calcium excretion, in the absence of primary renal or parathyroid gland disease, is a sensitive indicator of total body calcium balance. We have shown that renal calcium excretion correlates with blood levels of 25-hydroxy-vitamin D levels in older children and urine calcium-to-creatinine ratios have been shown to distinguish children with active rickets from healthy controls in one Nigerian study. This biomarker is noninvasive and the assays are straight forward and inexpensive. We believe that the urine calcium-to-creatinine ratio has excellent potential as a screening tool for vitamin D deficiency.
Objective and Hypotheses. The objective of this study is to evaluate the urine calcium-to-creatinine ratio as a biomarker of vitamin D deficiency. Our hypotheses are 1) that urine calcium-to-creatinine ratio correlates with serum 25-hydroxy vitamin D level in infants and toddlers at risk for vitamin D deficiency and 2) that the urine calcium-to-creatinine ratio can be used to screen children for vitamin D deficiency. These hypotheses will be tested through two specific aims. Specific Aim 1 is to determine the correlation between the urine calcium-to-creatinine ratio with 25-hydroxy vitamin D levels and with biomarkers of rickets in infants and toddlers at increased risk for vitamin D deficiency. Specific Aim 2 is to determine the sensitivity, specificity, and positive and negative predictive values of one random urine calcium-to-creatinine ratio in relation to biochemical evidence of vitamin D deficiency.
Design. This will be an observational study of infants and toddlers at increased risk for vitamin D deficiency. We will recruit 150 healthy children, 6 to 36 months of age, with risk factors for vitamin D deficiency (premature birth, breast feeding, dairy product avoidance, etc.). Based on previous studies in the US, we anticipate about 12% of these subjects will have vitamin D deficiency. Subjects will have a physical exam targeted to signs of rickets. Laboratories will include a random urine sample for calcium-to-creatinine ratio and blood for calcium, creatinine, alkaline phosphatase, phosphorus, magnesium, intact PTH, and 25-hydroxy vitamin D. Subjects with biochemical evidence of rickets will have x-rays done of the left wrist and knees that will be scored according to previously published rickets scores.
Potential Impact. Vitamin D deficiency is increasingly recognized as a common source of morbidity in both developed and undeveloped countries. The validation of a noninvasive and inexpensive screening tool for vitamin D deficiency would allow for large scale screening of at risk populations and detect this problem early, preventing the morbidities of rickets.
Study design
- Observational model
- Cohort
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 6 months to 3 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child
- Study population
- Infants and Toddlers from 6 months to 3 years part of a group known to be in at least one high-risk group for vitamin D deficiency: 1. child has been exclusively breast fedfor at least 1 month 2. darkly pigmented children 3. children born at a gestational age of 32 weeks or less 4. recent immigrant from developed country 5. child is underweight (wt/ht < 10%) 6. children with bowed legs or wrist enlargement
Key inclusion criteria (1 listed)
- In one of the 6 high-risk groups between the age of 6 months and 3 years.
Key exclusion criteria (7 listed)
- known familial rickets (hypophosphatemic or vitamin D resistant)
- known parathyroid hormone problems
- any child on diuretics
- presence of a chronic disease or use of medications known to affect vitamin D metabolism
- renal insufficiency
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Not reported in the source record.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Sep 2011.
- Background: PubMed 18450891Olney RC, Mazur JM, Pike LM, Froyen MK, Ramirez-Garnica G, Loveless EA, Mandel DM, Hahn GA, Neal KM, Cummings RJ. Healthy children with frequent fractures: how much evaluation is needed? Pediatrics. 2008 May;121(5):890-7. doi: 10.1542/peds.2007-2079.
- Background: PubMed 18524739Gordon CM, Feldman HA, Sinclair L, Williams AL, Kleinman PK, Perez-Rossello J, Cox JE. Prevalence of vitamin D deficiency among healthy infants and toddlers. Arch Pediatr Adolesc Med. 2008 Jun;162(6):505-12. doi: 10.1001/archpedi.162.6.505.
- Background: PubMed 10893912Thacher TD, Fischer PR, Pettifor JM, Lawson JO, Manaster BJ, Reading JC. Radiographic scoring method for the assessment of the severity of nutritional rickets. J Trop Pediatr. 2000 Jun;46(3):132-9. doi: 10.1093/tropej/46.3.132.
- Background: PubMed 10969262Thacher TD, Fischer PR, Pettifor JM, Lawson JO, Isichei CO, Chan GM. Case-control study of factors associated with nutritional rickets in Nigerian children. J Pediatr. 2000 Sep;137(3):367-73. doi: 10.1067/mpd.2000.107527.
- Background: PubMed 12369487Thacher TD, Fischer PR, Pettifor JM. The usefulness of clinical features to identify active rickets. Ann Trop Paediatr. 2002 Sep;22(3):229-37. doi: 10.1179/027249302125001525.
Related trials for Vitamin D Deficiency
RecruitingPhase 1/2
A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia
X-linked Hypophosphatemia
Not yet recruitingPhase 2
REducing Systemic Inflammation With LOw-dose Colchicine to ImproVE Cardiovascular Calcification in Chronic Kidney Disease: A Pilot Randomized Open-Label Trial
Chronic Kidney Disease Mineral and Bone Disorder, Cognitive Function
Recruiting
Role of Vitamin D Supplementation in Children With Irritable Bowel Syndrome
Irritable Bowel Syndrome (IBS), Vitamin D Deficiency
RecruitingObservational study
Post Marketing Surveillance Study to Observe Safety and Effectiveness of CRYSVITA® in S. Korean Patients
FGF23-related Hypophosphataemic Rickets and Osteomalacia
Not yet recruiting
Effect of Vitamin D Supplementation Added to Iron Therapy in Children With Iron Deficiency Anemia
Iron Deficiency Anemia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Robert Olney, MD principal investigator
Nemours Children's Clinic
Matthew Benson, MD study director
Nemours Children's Clinic
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Vitamin D Deficiency, run by Nemours Children's Clinic at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 9 Sep 2011. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT01105689, which also lists 5 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Sep 2011.